John G. Vossen

Develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability

Brightlands Venture invests in companies located in Europe. The firm focuses on health, agrifood and renewable chemistry. It participates in seed and early stage capital requirements with an investment size of EUR 0.25 - EUR 2 million. The firm acts as lead and co-investor and makes follow-on investments.

BOM invests in companies located across the globe primarily in Netherlands. The firm focuses on decentralized energy systems, medtech & life sciences, plant based, deep tech, AI-tech and defense sectors. It participates in early stage capital requirements with an investment size between EUR 0.2 and 5 million. The firm acquires minority interest.

LVM is an active manager which invests in start-up companies in the life sciences (cardiovascular and oncology research, nutrition and health, biomaterials and biomedical devices and biopharmaceuticals) and advanced materials sectors (functional polymers, coatings and films, formulations and processing activities) which relocate to the Dutch province of Limburg. The firm typically invests between EUR 0.25-2 million in companies still in the start-up phase which are close to achieving proof-of-principle status, ready to scale up and commercialize proprietary technology. In certain cases, they also invest in companies supplying or servicing such firms. LVM acts as lead investor and also participates as a co-investor in a syndicate. They generally take a board seat, partnering with investee company management to help create value.

LIOF invests in small and mid-size companies located in the Netherlands. The firm targets companies operating in the field of ICT, technology-related, life science, manufacturing, chemicals, new materials, automotive services, consumer non-durables, leisure and health sectors. It provides financing in the form of equity and subordinated loan for pre-seed, seed and early stage capital requirements with an investment size of EUR 0.1 - 5 million. The firm acquires majority & minority interests and also makes co-investments.